D. Le-but, une telle classification est d'établir des listes de gènes candidats pour le phénotype de la Trisomie 21. Ainsi, les gènes constamment surexprimés mais non compensés, 27 + 7 = 34%) seraient potentiellement responsable du phénotype de la Trisomie 21 alors que les gènes variables expliqueraient les différences entre les individus porteurs de Trisomie 21, 2007.

C. Aguado, J. Colon, F. Ciruela, F. Schlaudraff, M. J. Cabanero et al., Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum, Journal of Neurochemistry, vol.20, issue.521, 2007.
DOI : 10.1006/mcne.1997.0614

K. J. Ahn, H. K. Jeong, H. S. Choi, S. R. Ryoo, Y. J. Kim et al., DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects, Neurobiology of Disease, vol.22, issue.3, pp.463-72, 2006.
DOI : 10.1016/j.nbd.2005.12.006

A. Yahya-graison, E. Aubert, J. Dauphinot, L. Rivals, I. Prieur et al., Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes, The American Journal of Human Genetics, vol.81, issue.3, pp.475-91, 2007.
DOI : 10.1086/520000

URL : https://hal.archives-ouvertes.fr/hal-01197498

E. C. Akeson, J. P. Lambert, S. Narayanswami, K. Gardiner, L. J. Bechtel et al., Ts65Dn ??? localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome, Cytogenetic and Genome Research, vol.93, issue.3-4, pp.3-4270, 2001.
DOI : 10.1159/000056997

K. Aldridge, R. H. Reeves, L. E. Olson, and J. T. Richtsmeier, Differential effects of trisomy on brain shape and volume in related aneuploid mouse models, American Journal of Medical Genetics Part A, vol.7, issue.10, 2007.
DOI : 10.1002/ajmg.a.31721

X. Altafaj, M. Dierssen, C. Baamonde, E. Martí, J. Visa et al., Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome, Human Molecular Genetics, vol.10, issue.18, pp.1915-1938, 2001.
DOI : 10.1093/hmg/10.18.1915

K. Amano, H. Sago, C. Uchikawa, T. Suzuki, S. E. Kotliarova et al., Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome, Human Molecular Genetics, vol.13, issue.13, pp.131333-131373, 2004.
DOI : 10.1093/hmg/ddh154

S. E. Antonarakis and C. J. Epstein, The challenge of Down syndrome, Trends in Molecular Medicine, vol.12, issue.10, pp.473-482, 2006.
DOI : 10.1016/j.molmed.2006.08.005

A. Armakolas and A. J. Klar, Left-Right Dynein Motor Implicated in Selective Chromatid Segregation in Mouse Cells, Science, vol.315, issue.5808, pp.315100-315101, 2007.
DOI : 10.1126/science.1129429

J. R. Arron, M. M. Winslow, A. Polleri, C. P. Chang, H. Wu et al., NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21, Nature, vol.100, issue.7093, pp.441595-600, 2006.
DOI : 10.1038/nature04678

M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler et al., Gene Ontology: tool for the unification of biology, Nature Genetics, vol.9, issue.1, pp.25-34, 2000.
DOI : 10.1038/75556

E. H. Aylward, R. Habbak, A. C. Warren, M. B. Pulsifer, P. E. Barta et al., Cerebellar Volume in Adults With Down Syndrome, Archives of Neurology, vol.54, issue.2, pp.209-221, 1997.
DOI : 10.1001/archneur.1997.00550140077016

C. D. Baldus, S. Liyanarachchi, K. Mrózek, H. Auer, S. M. Tanner et al., Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes, Proceedings of the National Academy of Sciences, vol.101, issue.11, pp.1013915-1013935, 2004.
DOI : 10.1073/pnas.0400272101

L. L. Baxter, T. H. Moran, J. T. Richtsmeier, J. Troncoso, H. et al., Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse, Human Molecular Genetics, vol.9, issue.2, pp.195-202, 2000.
DOI : 10.1093/hmg/9.2.195

V. Beisvag, F. K. Junge, H. Bergum, L. Jolsum, S. Lydersen et al., Genetools? application for functional annotation and statistical hypothesis testing, BMC Bioinformatics, vol.7, issue.1, p.470, 2006.
DOI : 10.1186/1471-2105-7-470

P. V. Belichenko, A. M. Kleschevnikov, A. Salehi, C. J. Epstein, and W. C. Mobley, Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype-phenotype relationships, The Journal of Comparative Neurology, vol.8, issue.Suppl, pp.329-374, 2007.
DOI : 10.1002/cne.21433

Y. Benjamini and Y. Hochberg, Controlling the false discovery rate : a practical and powerful approach to multiple testing, J Roy Stat Soc B, vol.57, pp.289-300, 1995.

C. N. Berger and C. J. Epstein, Delayed thymocyte maturation in the trisomy 16 mouse fetus, Cell Differentiation and Development, vol.27, issue.2, pp.389-96, 1989.
DOI : 10.1016/0922-3371(89)90212-8

T. K. Best, R. J. Siarey, and Z. Galdzicki, Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABAB-Induced Potassium Current, Journal of Neurophysiology, vol.97, issue.1, pp.892-900, 2007.
DOI : 10.1152/jn.00626.2006

J. A. Birchler, A study of enzyme activities in a dosage series of the long arm of chromosome one in maize, Genetics, vol.92, issue.4, pp.1211-1229, 1979.

J. A. Birchler, N. C. Riddle, D. L. Auger, and R. A. Veitia, Dosage balance in gene regulation: biological implications, Trends in Genetics, vol.21, issue.4, pp.219-245, 2005.
DOI : 10.1016/j.tig.2005.02.010

A. Bush and N. Beail, Risk Factors for Dementia in People With Down Syndrome: Issues in Assessment and Diagnosis, American Journal on Mental Retardation, vol.109, issue.2, pp.83-97, 2004.
DOI : 10.1352/0895-8017(2004)109<83:RFFDIP>2.0.CO;2

M. Bustin, P. J. Alfonso, J. M. Pash, J. M. Ward, J. D. Gearhart et al., Characterization of Transgenic Mice with an Increased Content of Chromosomal Protein HMG-14 in Their Chromatin, DNA and Cell Biology, vol.14, issue.12, pp.14997-1005, 1995.
DOI : 10.1089/dna.1995.14.997

A. R. Caputo, R. S. Wagner, D. R. Reynolds, S. Q. Guo, and A. K. Goel, Down Syndrome: Clinical Review of Ocular Features, Clinical Pediatrics, vol.28, issue.8, pp.28355-28363, 1989.
DOI : 10.1177/000992288902800804

L. Chakrabarti, Z. Galdzicki, and T. F. Haydar, Defects in Embryonic Neurogenesis and Initial Synapse Formation in the Forebrain of the Ts65Dn Mouse Model of Down Syndrome, Journal of Neuroscience, vol.27, issue.43, pp.2711483-95, 2007.
DOI : 10.1523/JNEUROSCI.3406-07.2007

K. T. Chang, Y. J. Shi, M. , and K. T. , The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: Implications for mental retardation, Proceedings of the National Academy of Sciences, vol.100, issue.26, pp.10015794-10015803, 2003.
DOI : 10.1073/pnas.2536696100

K. G. Chen, G. Szakacs, J. P. Annereau, F. Rouzaud, X. J. Liang et al., ???5 in melanoma cells and melanocytes, Pigment Cell Research, vol.14, issue.2, pp.102-114, 2005.
DOI : 10.1111/j.1600-0749.2005.00214.x

M. A. Chernousov and D. J. Carey, ??V??8 integrin is a Schwann cell receptor for fibrin, Experimental Cell Research, vol.291, issue.2, pp.514-538, 2003.
DOI : 10.1016/S0014-4827(03)00409-9

R. Chrast, H. S. Scott, R. Madani, L. Huber, D. P. Wolfer et al., Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome, Human Molecular Genetics, vol.9, issue.12, pp.1853-64, 2000.
DOI : 10.1093/hmg/9.12.1853

A. Contestabile, T. Fila, R. Bartesaghi, C. , and E. , Cell Cycle Elongation Impairs Proliferation of Cerebellar Granule Cell Precursors in the Ts65Dn Mouse, an Animal Model for Down Syndrome, Brain Pathology, vol.16, issue.7, 2008.
DOI : 10.1111/j.1750-3639.2008.00168.x

A. Contestabile, T. Fila, C. Ceccarelli, P. Bonasoni, L. Bonapace et al., Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice, Hippocampus, vol.59, issue.8, pp.17665-78, 2007.
DOI : 10.1002/hipo.20308

A. C. Costa, K. Walsh, T. , and D. M. , Motor dysfunction in a mouse model for Down syndrome, Physiology & Behavior, vol.68, issue.1-2, pp.211-231, 1999.
DOI : 10.1016/S0031-9384(99)00178-X

L. Crome, V. Cowie, and E. Slater, A STATISTICAL NOTE ON CEREBELLAR AND BRAIN-STEM WEIGHT IN MONGOLISM, Journal of Intellectual Disability Research, vol.20, issue.1, pp.69-72, 1966.
DOI : 10.1111/j.1365-2788.1966.tb00173.x

D. Vecchia, L. K. Grosfeld, J. L. West, K. W. Rescorla, F. J. Scherer et al., Intestinal atresia and stenosis : a 25-year experience with 277 cases, Arch. Surg, vol.133, pp.490-496, 1998.

L. Dauphinot, R. Lyle, I. Rivals, M. T. Dang, R. X. Moldrich et al., The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome, Human Molecular Genetics, vol.14, issue.3, pp.373-84, 2005.
DOI : 10.1093/hmg/ddi033

M. T. Davisson, C. Schmidt, and E. C. Akeson, Segmental trisomy of murine chromosome 16 : a new model system for studying down syndrome, Prog Clin Biol Res, vol.360, pp.263-80, 1990.

J. M. Delabar, R. Aflalo-rattenbac, and N. Créau, Developmental Defects in Trisomy 21 and Mouse Models, The Scientific World JOURNAL, vol.6, pp.1945-64, 2006.
DOI : 10.1100/tsw.2006.322

J. M. Delabar, D. Theophile, Z. Rahmani, Z. Chettouh, J. L. Blouin et al., Molecular mapping of twenty-four features of Down syndrome on chromosome 21, Eur J Hum Genet, vol.1, issue.2, pp.114-138, 1993.

R. H. Devlin, D. G. Holm, and T. A. Grigliatti, Autosomal dosage compensation Drosophila melanogaster strains trisomic for the left arm of chromosome 2., Proceedings of the National Academy of Sciences, vol.79, issue.4, pp.1200-1204, 1982.
DOI : 10.1073/pnas.79.4.1200

M. Dierssen, I. F. Vallina, C. Baamonde, M. A. Lumbreras, C. Martínez-cué et al., Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model, Developmental Brain Research, vol.95, issue.1, pp.122-126, 1996.
DOI : 10.1016/0165-3806(96)00071-5

F. Duprat, F. Lesage, E. Guillemare, M. Fink, J. P. Hugnot et al., Heterologous Multimeric Assembly Is Essential for K+ Channel Activity of Neuronal and Cardiac G-Protein-Activated Inward Rectifiers, Biochemical and Biophysical Research Communications, vol.212, issue.2, 1995.
DOI : 10.1006/bbrc.1995.2019

M. Ema, S. Ikegami, T. Hosoya, J. Mimura, H. Ohtani et al., Mild Impairment of Learning and Memory in Mice Overexpressing the mSim2 Gene Located on Chromosome 16: An Animal Model of Down's Syndrome, Human Molecular Genetics, vol.8, issue.8, pp.1409-1424, 1999.
DOI : 10.1093/hmg/8.8.1409

C. J. Epstein, From Down Syndrome to the ???Human??? in ???Human Genetics???**Previously presented at the annual meeting of The American Society of Human Genetics, in San Diego, on October 15, 2001., The American Journal of Human Genetics, vol.70, issue.2, pp.300-313, 2002.
DOI : 10.1086/338915

C. J. Epstein, K. B. Avraham, M. Lovett, S. Smith, O. Elroy-stein et al., Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome., Proceedings of the National Academy of Sciences, vol.84, issue.22, pp.848044-848052, 1987.
DOI : 10.1073/pnas.84.22.8044

C. J. Epstein, B. G. Hofmeister, D. Yee, S. A. Smith, R. Philip et al., Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16, Journal of Experimental Medicine, vol.162, issue.2, pp.695-712, 1985.
DOI : 10.1084/jem.162.2.695

C. J. Epstein, N. H. Mcmanus, L. B. Epstein, A. A. Branca, S. B. D-'alessandro et al., Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-?? receptor, Biochemical and Biophysical Research Communications, vol.107, issue.3, pp.1060-1066, 1982.
DOI : 10.1016/0006-291X(82)90629-5

L. B. Epstein and C. J. Epstein, Localization of the Gene AVG for the Antiviral Expression of Immune and Classical Interferon to the Distal Portion of the Long Arm of Chromosome 21, Journal of Infectious Diseases, vol.133, issue.Supplement 2, pp.56-62, 1976.
DOI : 10.1093/infdis/133.Supplement_2.A56

L. B. Epstein, S. H. Lee, and C. J. Epstein, Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon, Cellular Immunology, vol.50, issue.1, pp.191-195, 1980.
DOI : 10.1016/0008-8749(80)90017-9

J. E. Esquirol, Traité des maladies mentales considérées sous le rapport médical , hygiénique et médico-légal, 1838.

F. Fabbro, A. Alberti, C. Gagliardi, and R. Borgatti, Differences in native and foreign language repetition tasks between subjects with William's and Down's syndromes, Journal of Neurolinguistics, vol.15, issue.1, pp.1-10, 2002.
DOI : 10.1016/S0911-6044(00)00016-6

D. R. Fitzpatrick, J. Ramsay, N. I. Mcgill, M. Shade, A. D. Carothers et al., Transcriptome analysis of human autosomal trisomy, Human Molecular Genetics, vol.11, issue.26, pp.113249-56, 2002.
DOI : 10.1093/hmg/11.26.3249

S. P. Fodor, J. L. Read, M. C. Pirrung, L. Stryer, A. T. Lu et al., Lightdirected , spatially addressable parallel chemical synthesis, Science, issue.4995, pp.251767-73, 1991.

S. B. Freeman, L. F. Taft, K. J. Dooley, K. Allran, S. L. Sherman et al., Population-based study of congenital heart defects in Down syndrome, American Journal of Medical Genetics, vol.92, issue.3, pp.213-220, 1998.
DOI : 10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8

E. Gahtan, J. M. Auerbach, Y. Groner, and M. Segal, Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice, European Journal of Neuroscience, vol.276, issue.2, pp.538-582, 1998.
DOI : 10.1006/abbi.1995.1263

Z. Galdzicki and R. J. Siarey, Understanding mental retardation in Down's syndrome using trisomy 16 mouse models, Genes, Brain and Behavior, vol.58, issue.3, pp.167-78, 2003.
DOI : 10.1016/S1388-2457(99)00086-3

K. Gardiner and M. Davisson, The sequence of human chromosome 21 and implications for research into Down syndrome, Genome Biol, vol.1, issue.2, 2000.

K. Gardiner, A. Fortna, L. Bechtel, and M. T. Davisson, Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions, Gene, vol.318, pp.137-184, 2003.
DOI : 10.1016/S0378-1119(03)00769-8

S. Giannone, P. Strippoli, L. Vitale, R. Casadei, S. Canaider et al., Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome, Annals of Human Genetics, vol.124, issue.6, 2004.
DOI : 10.1046/j.1529-8817.2003.00123.x

Y. Groner, Transgenic models for chromosome 21 gene dosage effects, Prog Clin Biol Res, vol.393, pp.193-212, 1995.

A. Gropp, D. Giers, and U. Kolbus, Trisomy in the fetal backcross progeny of male and female met acentric heterozygotes of the mouse. I, Cytogenetic and Genome Research, vol.13, issue.6, pp.511-546, 1974.
DOI : 10.1159/000130304

S. Guidi, P. Bonasoni, C. Ceccarelli, D. Santini, F. Gualtieri et al., Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome, Brain Pathol, 2007.

M. Guo, D. Davis, and J. A. Birchler, Dosage effects on gene expression in a maize ploidy series, Genetics, vol.142, issue.4, pp.1349-55, 1996.

C. Harashima, D. M. Jacobowitz, M. Stoffel, L. Chakrabarti, T. F. Haydar et al., Elevated Expression of the G-Protein-Activated Inwardly Rectifying Potassium Channel 2 (GIRK2) in Cerebellar Unipolar Brush Cells of a Down Syndrome Mouse Model, Cellular and Molecular Neurobiology, vol.86, issue.Pt 4, pp.4-6719, 2006.
DOI : 10.1007/s10571-006-9066-4

A. B. Harkins and A. P. Fox, Cell death in weaver mouse cerebellum, The Cerebellum, vol.1, issue.3, pp.201-207, 2002.
DOI : 10.1080/14734220260418420

C. D. Harris, G. Ermak, and K. J. Davies, Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product Calcipressin 1 (or RCAN1) in disease, Cellular and Molecular Life Sciences, vol.62, issue.21, pp.622477-86, 2005.
DOI : 10.1007/s00018-005-5085-4

C. Harris-cerruti, A. Kamsler, B. Kaplan, B. Lamb, M. Segal et al., Functional and morphological alterations in compound transgenic mice overexpreszing Cu/Zn superoxide dismutaze and amyloid precursor protein, European Journal of Neuroscience, vol.19, issue.5, pp.1174-90, 2004.
DOI : 10.1016/0896-6273(95)90259-7

M. Hattori and C. Mapping, and sequencing consortium The dna sequence of human chromosome 21, Nature, issue.6784, pp.405311-405320, 2000.

T. F. Haydar, R. S. Nowakowski, P. J. Yarowsky, and B. K. Krueger, Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse, J Neurosci, vol.20, issue.11, pp.4156-64, 2000.

D. M. Holtzman, D. Santucci, J. Kilbridge, J. Chua-couzens, D. J. Fontana et al., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome, Proceedings of the National Academy of Sciences, vol.93, issue.23, pp.9313333-9313341, 1996.
DOI : 10.1073/pnas.93.23.13333

A. Huang, C. S. Ho, R. Ponzielli, D. Barsyte-lovejoy, E. Bouffet et al., Identification of a Novel c-Myc Protein Interactor, JPO2, with Transforming Activity in Medulloblastoma Cells, Cancer Research, vol.65, issue.13, pp.655607-655626, 2005.
DOI : 10.1158/0008-5472.CAN-05-0500

A. Ieshima, T. Kisa, K. Yoshino, S. Takashima, and K. Takaeshita, A morphometric CT study of Down's syndrome showing small posterior fossa and calcification of basal ganglia, Neuroradiology, vol.27, issue.6, pp.493-498, 1984.
DOI : 10.1007/BF00342687

A. M. Insausti, M. Megías, D. Crespo, L. M. Cruz-orive, M. Dierssen et al., Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome, Neuroscience Letters, vol.253, issue.3, pp.175-183, 1998.
DOI : 10.1016/S0304-3940(98)00641-7

J. H. Ives, F. Dagna-bricarelli, G. Basso, S. E. Antonarakis, R. Jee et al., Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor(TIAM1) mRNA in bone marrow of down syndrome children during the acute phase of AML(M7), Genes, Chromosomes and Cancer, vol.9, issue.1, pp.61-67, 1998.
DOI : 10.1002/(SICI)1098-2264(199809)23:1<61::AID-GCC9>3.0.CO;2-4

D. Jaarsma, E. D. Haasdijk, J. A. Grashorn, R. Hawkins, W. Van-duijn et al., Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1, Neurobiology of Disease, vol.7, issue.6, pp.623-666, 2000.
DOI : 10.1006/nbdi.2000.0299

Y. Kagami and T. Furuichi, Investigation of differentially expressed genes during the development of mouse cerebellum, Gene Expression Patterns, vol.1, issue.1, pp.39-59, 2001.
DOI : 10.1016/S1567-133X(01)00007-2

P. Kahlem, M. Sultan, R. Herwig, M. Steinfath, D. Balzereit et al., Transcript Level Alterations Reflect Gene Dosage Effects Across Multiple Tissues in a Mouse Model of Down Syndrome, Genome Research, vol.14, issue.7, pp.1258-67, 2004.
DOI : 10.1101/gr.1951304

P. Kapranov, S. E. Cawley, J. Drenkow, S. Bekiranov, R. L. Strausberg et al., Large-Scale Transcriptional Activity in Chromosomes 21 and 22, Science, vol.296, issue.5569, pp.296916-296925, 2002.
DOI : 10.1126/science.1068597

I. Kola and P. J. Hertzog, Down syndrome and mouse models, Current Opinion in Genetics & Development, vol.8, issue.3, pp.316-337, 1998.
DOI : 10.1016/S0959-437X(98)80088-9

I. Kola and M. Pritchard, Animal models of Down syndrome, Molecular Medicine Today, vol.5, issue.6, pp.276-283, 1999.
DOI : 10.1016/S1357-4310(99)01486-0

J. R. Korenberg, X. N. Chen, R. Schipper, Z. Sun, R. Gonsky et al., Down syndrome phenotypes : the consequences of chromosomal imbalance, pp.914997-5001, 1994.

M. A. Kurt, D. C. Davies, M. Kidd, M. Dierssen, and J. Flórez, Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice, Brain Research, vol.858, issue.1, pp.191-198, 2000.
DOI : 10.1016/S0006-8993(00)01984-3

M. A. Kurt, M. I. Kafa, M. Dierssen, and D. C. Davies, Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome, Brain Research, vol.1022, issue.1-2, pp.101-110, 2004.
DOI : 10.1016/j.brainres.2004.06.075

B. T. Lamb, S. S. Sisodia, A. M. Lawler, H. H. Slunt, C. A. Kitt et al., Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice, Nature Genetics, vol.10, issue.1, pp.22-30, 1993.
DOI : 10.1016/0378-1119(91)90093-Q

L. Brigand, K. Russell, R. Moreilhon, C. Rouillard, J. M. Jost et al., An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes, Nucleic Acids Research, vol.34, issue.12, p.87, 2006.
DOI : 10.1093/nar/gkl485

URL : https://hal.archives-ouvertes.fr/hal-00088266

J. Lejeune, M. Gauthier, and R. Turpin, Etude des chromosomes somatiques de neuf enfants mongoliens, CR Acad. des Sciences, vol.248, issue.11, pp.1721-1723, 1959.

J. Lejeune, M. Gauthier, and R. Turpin, Les chromosomes humains en culture de tissus, CR Acad. des Sciences, vol.248, issue.4, pp.602-605, 1959.

F. Lesage, E. Guillemare, M. Fink, F. Duprat, C. Heurteaux et al., Molecular Properties of Neuronal G-protein-activated Inwardly Rectifying K+ Channels, Journal of Biological Chemistry, vol.270, issue.48, pp.28660-28667, 1995.
DOI : 10.1074/jbc.270.48.28660

K. L. Ligon, S. P. Fancy, R. J. Franklin, R. , and D. H. , Olig gene function in CNS development and disease, Glia, vol.31, issue.1, pp.1-10, 2006.
DOI : 10.1002/glia.20273

H. E. Lockstone, L. W. Harris, J. E. Swatton, M. T. Wayland, A. J. Holland et al., Gene expression profiling in the adult Down syndrome brain, Genomics, vol.90, issue.6, pp.90647-60, 2007.
DOI : 10.1016/j.ygeno.2007.08.005

H. A. Lorenzi and R. H. Reeves, Hippocampal hypocellularity in the Ts65Dn mouse originates early in development, Brain Research, vol.1104, issue.1, pp.153-162, 2006.
DOI : 10.1016/j.brainres.2006.05.022

I. T. Lott and E. Head, Alzheimer disease and Down syndrome: factors in pathogenesis, Neurobiology of Aging, vol.26, issue.3, pp.383-392, 2005.
DOI : 10.1016/j.neurobiolaging.2004.08.005

A. Ma-'ayan, K. Gardiner, and R. Iyengar, The cognitive phenotype of Down syndrome : insights from intracellular network analysis, NeuroRx, vol.3, issue.3, pp.396-406, 2006.

R. Mao, X. Wang, E. L. Spitznagel, L. P. Frelin, J. C. Ting et al., Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart, Genome Biol, vol.6, issue.13, 2005.

R. Mao, C. L. Zielke, H. R. Zielke, and J. Pevsner, Global up-regulation of chromosome 21 gene expression in the developing down syndrome brain, Genomics, vol.81, issue.5, pp.457-67, 2003.
DOI : 10.1016/S0888-7543(03)00035-1

F. M. Mikhail, L. Coignet, N. Hatem, Z. I. Mourad, H. M. Farawela et al., A novel gene,FGA7, is fused toRUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, vol.88, issue.2, pp.110-118, 2004.
DOI : 10.1002/gcc.10302

R. X. Moldrich, A yeast model of Down syndrome, International Journal of Developmental Neuroscience, vol.25, issue.8, pp.539-582, 2007.
DOI : 10.1016/j.ijdevneu.2007.10.001

R. X. Moldrich, L. Dauphinot, J. Laffaire, J. Rossier, and M. C. Potier, Down syndrome gene dosage imbalance on cerebellum development, Progress in Neurobiology, vol.82, issue.2, pp.87-94, 2007.
DOI : 10.1016/j.pneurobio.2007.02.006

S. Nakanishi and M. Okazawa, signalling in development and maturation of mammalian cerebellar granule cells, The Journal of Physiology, vol.16, issue.2, pp.389-95, 2006.
DOI : 10.1113/jphysiol.2006.113340

S. A. Narod, C. Stiller, and G. M. Lenoir, An estimate of the heritable fraction of childhood cancer, British Journal of Cancer, vol.63, issue.6, pp.993-1002, 1991.
DOI : 10.1038/bjc.1991.216

O. Doherty, A. Ruf, S. Mulligan, C. Hildreth, V. Errington et al., An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes, Science, vol.309, issue.5743, pp.2033-2040, 2005.
DOI : 10.1126/science.1114535

L. E. Olson, R. J. Roper, L. L. Baxter, E. J. Carlson, C. J. Epstein et al., Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes, Developmental Dynamics, vol.2, issue.3, pp.581-590, 2004.
DOI : 10.1002/dvdy.20079

L. E. Olson, R. J. Roper, C. L. Sengstaken, E. A. Peterson, V. Aquino et al., Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice, Human Molecular Genetics, vol.16, issue.7, pp.774-82, 2007.
DOI : 10.1093/hmg/ddm022

X. M. Ou, K. Chen, and J. C. Shih, Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway, Proceedings of the National Academy of Sciences, vol.103, issue.29, pp.10923-10931, 2006.
DOI : 10.1073/pnas.0601515103

N. Patil, D. Cox, D. Bhat, M. Faham, R. M. Myers et al., A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation, Nature Genetics, vol.4, issue.2, pp.126-135, 1995.
DOI : 10.1006/bbrc.1995.1456

B. F. Pennington, J. Moon, J. Edgin, J. Stedron, and L. Nadel, The Neuropsychology of Down Syndrome: Evidence for Hippocampal Dysfunction, Child Development, vol.231, issue.1, pp.75-93, 2003.
DOI : 10.1006/brcg.1995.1267

J. D. Pinter, S. Eliez, J. E. Schmitt, G. T. Capone, and A. L. Reiss, Neuroanatomy of Down???s Syndrome: A High-Resolution MRI Study, American Journal of Psychiatry, vol.158, issue.10, pp.1581659-65, 2001.
DOI : 10.1176/appi.ajp.158.10.1659

P. Prandini, S. Deutsch, R. Lyle, M. Gagnebin, D. Vivier et al., Natural Gene-Expression Variation in Down Syndrome Modulates the Outcome of Gene-Dosage Imbalance, The American Journal of Human Genetics, vol.81, issue.2, pp.252-63, 2007.
DOI : 10.1086/519248

M. A. Pritchard and I. Kola, The ???gene dosage effect??? hypothesis versus the ???amplified developmental instability??? hypothesis in Down syndrome, J Neural Transm, vol.57, pp.293-303, 1999.
DOI : 10.1007/978-3-7091-6380-1_20

B. Ramos, B. Gaudilliere, A. Bonni, and G. Gill, Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation, Proceedings of the National Academy of Sciences, vol.104, issue.23, pp.9882-9889, 2007.
DOI : 10.1073/pnas.0701946104

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887555

N. Raz, I. J. Torres, S. D. Briggs, W. D. Spencer, A. E. Thornton et al., Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates: Evidence from MRI morphometry, Neurology, vol.45, issue.2, pp.356-66, 1995.
DOI : 10.1212/WNL.45.2.356

R. H. Reeves, L. L. Baxter, and J. T. Richtsmeier, Too much of a good thing: mechanisms of gene action in Down syndrome, Trends in Genetics, vol.17, issue.2, pp.83-91, 2001.
DOI : 10.1016/S0168-9525(00)02172-7

R. H. Reeves, N. G. Irving, T. H. Moran, A. Wohn, C. Kitt et al., A mouse model for Down syndrome exhibits learning and behaviour deficits, Nature Genetics, vol.5, issue.2, pp.177-84, 1995.
DOI : 10.1016/0092-8674(86)90493-9

R. H. Reeves, J. Yao, M. R. Crowley, S. Buck, X. Zhang et al., Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice., Proceedings of the National Academy of Sciences, vol.91, issue.12, pp.915359-63, 1994.
DOI : 10.1073/pnas.91.12.5359

J. T. Richtsmeier, L. L. Baxter, and R. H. Reeves, Parallels of craniofacial maldevelopment in down syndrome and Ts65Dn mice, Developmental Dynamics, vol.5, issue.2, pp.137-182, 2000.
DOI : 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N

I. Rivals, L. Personnaz, L. Taing, and M. C. Potier, Enrichment or depletion of a GO category within a class of genes: which test?, Bioinformatics, vol.23, issue.4, pp.401-408, 2007.
DOI : 10.1093/bioinformatics/btl633

URL : https://hal.archives-ouvertes.fr/hal-00801557

N. J. Roizen and D. Patterson, Down's syndrome, The Lancet, vol.361, issue.9365, pp.1281-1290, 2003.
DOI : 10.1016/S0140-6736(03)12987-X

N. J. Roizen, C. Wolters, T. Nicol, and T. A. Blondis, Hearing loss in children with Down syndrome, The Journal of Pediatrics, vol.123, issue.1, pp.9-12, 1993.
DOI : 10.1016/S0022-3476(05)81588-4

R. J. Roper, L. L. Baxter, N. G. Saran, D. K. Klinedinst, P. A. Beachy et al., Defective cerebellar response to mitogenic hedgehog signaling in Down syndrome mice, pp.1452-1458, 2006.

P. L. Roubertoux, Z. Bichler, W. Pinoteau, Z. Seregaza, S. Fortes et al., Functional Analysis of Genes Implicated in Down Syndrome: 2. Laterality and Corpus Callosum Size in Mice Transpolygenic for Down Syndrome Chromosomal Region ?1 (DCR-1), Behavior Genetics, vol.20, issue.3, pp.333-374, 2005.
DOI : 10.1007/s10519-005-3225-0

URL : https://hal.archives-ouvertes.fr/hal-01441282

P. L. Roubertoux and B. Kerdelhué, Trisomy 21: From Chromosomes to Mental Retardation, Behavior Genetics, vol.37, issue.3, pp.346-54, 2006.
DOI : 10.1007/s10519-006-9052-0

N. Rueda, R. Mostany, A. Pazos, J. Florez, and C. Martinez-cue, Cell proliferation is reduced in the dentate gyrus of aged but not young Ts65Dn mice, a model of Down syndrome, Neuroscience Letters, vol.380, issue.1-2, pp.197-201, 2005.
DOI : 10.1016/j.neulet.2005.01.039

A. Ruiz-i-altaba, V. Palma, and N. Dahmane, HEDGEHOG???GLI SIGNALLING AND THE GROWTH OF THE BRAIN, Nature Reviews Neuroscience, vol.3, issue.1, pp.24-33, 2002.
DOI : 10.1038/nrn704

H. Sago, E. J. Carlson, D. J. Smith, J. Kilbridge, E. M. Rubin et al., Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities, Proceedings of the National Academy of Sciences, vol.95, issue.11, pp.956256-61, 1998.
DOI : 10.1073/pnas.95.11.6256

H. Sago, E. J. Carlson, D. J. Smith, E. M. Rubin, L. S. Crnic et al., Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome, Pediatric Research, vol.82, issue.5, pp.606-619, 2000.
DOI : 10.1203/00006450-200011000-00009

A. Salehi, J. D. Delcroix, P. V. Belichenko, K. Zhan, C. Wu et al., Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration, Neuron, vol.51, issue.1, pp.29-42, 2006.
DOI : 10.1016/j.neuron.2006.05.022

A. Salehi, M. Faizi, P. V. Belichenko, and W. C. Mobley, Using mouse models to explore genotype???phenotype relationship in Down syndrome, Mental Retardation and Developmental Disabilities Research Reviews, vol.276, issue.3, pp.207-221, 2007.
DOI : 10.1002/mrdd.20164

N. G. Saran, M. T. Pletcher, J. E. Natale, Y. Cheng, and R. H. Reeves, Global disruption of the cerebellar transcriptome in a Down syndrome mouse model, Human Molecular Genetics, vol.12, issue.16, pp.122013-122022, 2003.
DOI : 10.1093/hmg/ddg217

D. Satgé, A. J. Sasco, N. L. Carlsen, C. A. Stiller, H. Rubie et al., A lack of neuroblastoma in down syndrome : a study from 11 european countries, Cancer Res, vol.58, issue.3, pp.448-52, 1998.

D. Satgé, A. J. Sasco, D. Goldgar, M. Vekemans, and M. O. Réthoré, A 23-year-old woman with down syndrome, type 1 neurofibromatosis, and breast carcinoma, American Journal of Medical Genetics Part A, vol.79, issue.1, 2004.
DOI : 10.1002/ajmg.a.20429

D. Satgé, D. Sommelet, A. Geneix, M. Nishi, P. Malet et al., A tumor profile in Down syndrome, American Journal of Medical Genetics, vol.78, issue.3, pp.207-223, 1998.
DOI : 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q

D. Satge, A. J. Sasco, N. L. Carlsen, H. Rubie, and C. A. Stiller, A negative association between Down's syndrome and neuroblastoma, Archives of Disease in Childhood, vol.76, issue.1, p.80, 1997.
DOI : 10.1136/adc.76.1.79b

T. Schatton, G. F. Murphy, N. Y. Frank, K. Yamaura, A. M. Waaga-gasser et al., Identification of cells initiating human melanomas, Nature, vol.317, issue.7176, pp.451345-451354, 2008.
DOI : 10.1038/nature06489

D. Schmucker, Molecular diversity of Dscam: recognition of molecular identity in neuronal wiring, Nature Reviews Neuroscience, vol.127, issue.12, pp.915-935, 2007.
DOI : 10.1038/nrn2256

E. Seguin, Traitement moral, hygiène et éducation des idiots, 1846.

E. Seguin, Idiocy and its treatment by the physiological method, 1866.

B. L. Shapiro, Down syndrome???a disruption of homeostasis, American Journal of Medical Genetics, vol.97, issue.2, pp.241-69, 1983.
DOI : 10.1002/ajmg.1320140206

B. L. Shapiro, Developmental instability of the cerebellum and its relevance to Down syndrome, J Neural Transm Suppl, vol.61, pp.11-34, 2001.
DOI : 10.1007/978-3-7091-6262-0_2

A. Shumway-cook and M. H. Woollacott, Dynamics of Postural Control in the Child with Down Syndrome, Physical Therapy, vol.65, issue.9, pp.1315-1337, 1985.
DOI : 10.1093/ptj/65.9.1315

S. Signorini, Y. J. Liao, S. A. Duncan, L. Y. Jan, and M. Stoffel, Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2, Proceedings of the National Academy of Sciences, vol.94, issue.3, pp.94923-94930, 1997.
DOI : 10.1073/pnas.94.3.923

P. A. Slesinger, N. Patil, Y. J. Liao, Y. N. Jan, L. Y. Jan et al., Functional Effects of the Mouse weaver Mutation on G Protein???Gated Inwardly Rectifying K+ Channels, Neuron, vol.16, issue.2, pp.321-352, 1996.
DOI : 10.1016/S0896-6273(00)80050-1

D. J. Solecki, X. L. Liu, T. Tomoda, Y. Fang, and M. E. Hatten, Activated Notch2 Signaling Inhibits Differentiation of Cerebellar Granule Neuron Precursors by Maintaining Proliferation, Neuron, vol.31, issue.4, pp.31557-68, 2001.
DOI : 10.1016/S0896-6273(01)00395-6

C. Sotelo, Cellular and genetic regulation of the development of the cerebellar system, Progress in Neurobiology, vol.72, issue.5, pp.295-339, 2004.
DOI : 10.1016/j.pneurobio.2004.03.004

Z. Sérégaza, P. L. Roubertoux, M. Jamon, and B. Soumireu-mourat, Mouse Models of Cognitive Disorders in Trisomy 21: A Review, Behavior Genetics, vol.20, issue.3, pp.387-404, 2006.
DOI : 10.1007/s10519-006-9056-9

M. Sultan, I. Piccini, D. Balzereit, R. Herwig, N. G. Saran et al., Gene expression variation in Down's syndrome mice allows prioritization of candidate genes, Genome Biology, vol.8, issue.5, 2007.
DOI : 10.1186/gb-2007-8-5-r91

S. H. Sumarsono, T. J. Wilson, M. J. Tymms, D. J. Venter, C. M. Corrick et al., Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice, Nature, vol.379, issue.6565, pp.379534-537, 1996.
DOI : 10.1038/379534a0

D. M. Supp, M. Brueckner, M. R. Kuehn, D. P. Witte, L. A. Lowe et al., Targeted deletion of the atp binding domain of left-right dynein confirms its role in specifying development of left-right asymmetries, Development, issue.23, pp.1265495-504, 1999.

T. E. Sussan, A. Yang, F. Li, M. C. Ostrowski, and R. H. Reeves, Trisomy represses apc(min)-mediated tumours in mouse models of down's syndrome, Nature, issue.7174, pp.45173-45178, 2008.

Y. H. Tan, J. Tischfield, and F. H. Ruddle, THE LINKAGE OF GENES FOR THE HUMAN INTERFERON-INDUCED ANTIVIRAL PROTEIN AND INDOPHENOL OXIDASE-B TRAITS TO CHROMOSOME G-21, Journal of Experimental Medicine, vol.137, issue.2, pp.317-347, 1973.
DOI : 10.1084/jem.137.2.317

E. Thiery, S. Thomas, S. Vacher, A. L. Delezoide, J. M. Delabar et al., Chromosome 21 KIR channels in brain development, J Neural Transm, vol.67, pp.105-120, 2003.
DOI : 10.1007/978-3-7091-6721-2_9

Y. Tong, J. Wei, S. Zhang, J. A. Strong, S. R. Dlouhy et al., The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2, FEBS Letters, vol.168, issue.1, pp.63-71, 1996.
DOI : 10.1016/0014-5793(96)00632-1

E. M. Torres, T. Sokolsky, C. M. Tucker, L. Y. Chan, M. Boselli et al., Effects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast, Science, vol.317, issue.5840, pp.317916-317940, 2007.
DOI : 10.1126/science.1142210

A. G. Ugazio, R. Maccario, L. D. Notarangelo, and G. R. Burgio, Immunology of Down syndrome: A review, American Journal of Medical Genetics, vol.314, issue.1, pp.204-216, 1990.
DOI : 10.1002/ajmg.1320370742

S. Vicari, Memory development and intellectual disabilities, Acta Paediatrica, vol.51, issue.445, pp.60-63, 2004.
DOI : 10.1111/j.1651-2227.2004.tb03059.x

S. Vicari, Motor Development and Neuropsychological Patterns in Persons with Down Syndrome, Behavior Genetics, vol.7, issue.3, pp.355-64, 2006.
DOI : 10.1007/s10519-006-9057-8

S. Weis, G. Weber, A. Neuhold, and A. Rett, Down syndrome : Mr quantification of brain structures and comparison with normal control subjects, AJNR AM J Neuroradiol, vol.12, pp.1207-1218, 1991.

N. White, M. Alkire, and R. Haier, A voxel-based morphometric study of nondemented adults with Down Syndrome, NeuroImage, vol.20, issue.1, pp.393-403, 2003.
DOI : 10.1016/S1053-8119(03)00273-8

G. C. Windham, T. Bjerkedal, and F. Langmark, A POPULATION-BASED STUDY OF CANCER INCIDENCE IN TWINS AND IN CHILDREN WITH CONGENITAL MALFORMATIONS OR LOW BIRTH WEIGHT, NORWAY, 1967???1980, American Journal of Epidemiology, vol.121, issue.1, pp.49-56, 1985.
DOI : 10.1093/oxfordjournals.aje.a113982

K. E. Wisniewski, Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis, American Journal of Medical Genetics, vol.8, issue.S7, pp.274-81, 1990.
DOI : 10.1002/ajmg.1320370755

E. J. Wolvetang, T. J. Wilson, E. Sanij, J. Busciglio, T. Hatzistavrou et al., ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway, Human Molecular Genetics, vol.12, issue.3, pp.247-55, 2003.
DOI : 10.1093/hmg/ddg015

X. Zhou, Y. Qyang, J. R. Kelsoe, E. Masliah, and M. A. Geyer, Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice, Genes, Brain and Behavior, vol.143, issue.3, pp.269-76, 2007.
DOI : 10.1038/sj.mp.4001621